2nd GLP-1-Based Therapeutics Summit 2025 29th April 2025 - May 01, 2025 The 2nd GLP-1-Based Therapeutics Summit returns to tackle the challenges in best-in-class GLP-1 development and indication expansion with new clinical data, new preclinical data, and 18+ expert speakers including Eli Lily, Regeneron, Roche, Novo Nordisk, Fractyl Health and more at the forefront of the field
Multi-strain synbiotics, in particular, have been highlighted as more effective in modulating gut microbiota compared to single-strain synbiotics or individual probiotic or prebiotic therapies
However, despite these similarities, the dosage and formulation of these medications are different
Conflict of Interest: None Acknowledgements: None References 1
If you have pre-existing diabetic retinopathy, report any new or worsening visual symptoms to your doctor